 FOSTER CITY, Calif., Sept. 28, 2021 GLOBE NEWSWIRE -- Vaxcyte, Inc. Nasdaq: PCVX, a next-generation vaccine company seeking to improve global health by developing superior and novel vaccines designed to prevent or treat some of the most common and deadly infectious diseases worldwide, today announced that Company management will participate in a fireside chat at the Guggenheim 2nd Annual Vaccine and Infectious Disease Conference on Tuesday, October 5, 2021 at 11:30am ET. 